1.Correlation between self esteem and quality of life among epilepsy teenagers
Zhen WEN ; Gui-Feng NIE ; Jing MAN
Chinese Journal of Modern Nursing 2012;18(20):2386-2388
Objective To explore the correlation between self esteem and quality of life among epilepsy teenagers.Methods Totals of 100 teenagers with epilepsy were investigated with the epilepsy quality of life rating scale ( QOLIE-31 ) and the self-esteem scale (SES).Results The dimensions score of QOLIE-31 from high to low were energy ( 65.43 ± 18.25 ),emotion ( 65.08 ± 16.50 ),cognitive function ( 63.98 ± 19.11 ),life satisfaction(63.75 ± 12.25),social function(59.37 ± 16.85 ),worrying about seizures (58.20 ± 15.52) and worrying about drug use(51.25 ±20.59).The self-esteem level was positively correlated with the total score of life quality,energy,emotion,life satisfaction,and social function ( r =0.296,0.302,0.372,0.385,0.345 ; P <0.05),while it negatively correlated with the worrying about seizures( r =-0.212,P < 0.05 ).Conclusions The outstanding problem of teenagers with epilepsy is worrying about drug use,and the self esteem level can influence their quality of life.
2.Effects of the new compound codonopsis tablets on brain performance capacity of youth at high altitude.
Hong-jing NIE ; Pei-bing LI ; Wei-gui YANG ; Bing-nan DENG ; Hui-li ZHU ; Li-xia YU ; Rui-feng DUAN ; Hai WANG ; Zhao-li CHEN
Chinese Journal of Applied Physiology 2015;31(2):114-116
Adolescent
;
Altitude
;
Brain
;
drug effects
;
Codonopsis
;
chemistry
;
Drugs, Chinese Herbal
;
pharmacology
;
Humans
;
Tablets
3.Mutational analysis of MYO1E in Chinese children with familial steroid-resistant nephrotic syndrome.
Feng ZHAO ; Zi-Hua YU ; Yong-Hui YANG ; Xiao-Jing NIE ; Jun HUANG ; Cheng-Feng WANG ; Gui-Zhi XIA ; Guang-Ming CHEN
Chinese Journal of Contemporary Pediatrics 2014;16(4):349-355
OBJECTIVESteroid-resistant nephrotic syndrome (SRNS) with MYO1E mutations has been identified as autosomal recessive focal segmental glomerulosclerosis (FSGS). To date, only two homozygous mutations in the MYO1E gene were reported in three families with FSGS. This study aimed to examine mutations in the MYO1E gene in children with familial SRNS in the Han Chinese ethnic group.
METHODSBetween 2005 and 2010, peripheral blood samples were collected from the probands, their siblings and parents of four families with autosomal recessive SRNS in the Han Chinese ethnic group. Four probands were studied from nine patients. The mutational analysis of MYO1E was performed by polymerase chain reaction and direct DNA sequencing. Fifty-nine healthy volunteers with normal urine analysis were included as controls.
RESULTSTwenty-five MYO1E variants in the prohands from 4 families with SRNS were identified in this study. Among them, 24 variants were found in NCBI dbSNP. One heterozygous mutation IVS21-85G>A was found in the prohand from Family D, whereas it was absent in 59 normal Chinese controls. No splice site change caused by IVS21-85G>A was reported by analysis with NetGene2.
CONCLUSIONSMYO1E mutations are not a major cause of Chinese familial SRNS in this study.
Adolescent ; Adult ; Child ; Child, Preschool ; China ; ethnology ; DNA Mutational Analysis ; Female ; Humans ; Infant ; Male ; Middle Aged ; Mutation ; Myosin Type I ; genetics ; Nephrotic Syndrome ; congenital ; genetics
4.Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes.
Shan-ying PENG ; Wen-hui LIAO ; Zhen-gui NIE ; Yang LIU ; Lin WANG ; Feng WANG ; Wen-jie WANG
Acta Pharmaceutica Sinica 2010;45(9):1103-1108
This study is to explore the effect of ginkgolide B (BN52021) on the production of nitric oxide (NO), interleukin (IL)-6 and regulated upon activation normal T cell expressed and secreted (RANTES) from astrocytes induced by stimulators. Primary cultured rat astrocytes were stimulated with lipopolysaccharides (LPS), the production of NO was assayed using Griess reaction; U251 cells were stimulated with IL-1 beta, the contents of IL-6 and RANTES in the supernatant were measured using ELISA. The mRNA expressions of IL-6 and RANTES were detected using RT-PCR. LPS (10 ng mL(-1) to 10 microg mL(-1)) could stimulate rat astrocytes to produce NO in a dose-dependent manner. Ginkgolide B at the concentrations of 0.1-10 micromol L(-1) were shown to decrease NO production significantly. IL-1 beta could induce the mRNA expression and protein secretion of IL-6 from U251 cells, as well as RANTES. Ginkgolide B at concentrations of 0.1-10 micromol L(-1) were shown to inhibit RANTES secretion, and to inhibit mRNA expression of IL-6 and RANTES at concentration of 10 micromol L(-1). Ginkgolide B has inhibitory effect on the production of NO, IL-6 and RANTES from astrocytes treated with inflammatory stimulators.
Animals
;
Astrocytes
;
cytology
;
metabolism
;
Cell Line, Tumor
;
Cells, Cultured
;
Chemokine CCL5
;
genetics
;
metabolism
;
Dose-Response Relationship, Drug
;
Ginkgolides
;
administration & dosage
;
pharmacology
;
Glioblastoma
;
metabolism
;
pathology
;
Humans
;
Interleukin-1beta
;
Interleukin-6
;
genetics
;
secretion
;
Lactones
;
administration & dosage
;
pharmacology
;
Lipopolysaccharides
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Nitric Oxide
;
metabolism
;
Platelet Activating Factor
;
antagonists & inhibitors
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Wistar
5.Effects of crystalloid and colloid coload on placental circulation of puerperae underwent spinal-epidural anesthesia
Ning LI ; Feng YUAN ; Yu-Yan NIE ; Yi XIE ; Zhong-Peng FU ; Gui-Qi GENG ; Shao-Qiang HUANG
Chinese Journal of Clinical Medicine 2016;23(6):759-763
Objective:To compare the effects of crystalloid and colloid coload on placental circulation for puerperae underwent spinal‐epidural anesthesia and fetus .Methods : Totally 100 cases scheduled for planned cesarean delivery under spinal anesthesia were recruited for this study .American Society of Anesthesiologists (ASA) score was Ⅰ‐Ⅱ .Parturients were randomly selected into H group and R group ,with 50 cases in each group .H group was received 6% hydroxyethyl starch 130/0 .4 sodium chloride injection ,while the R group was applied with Lactated Ringer solution .Two groups were received speedy injection of HES or Lactated Ringer solution before spinal‐epidural anesthesia ,the speed with 0 .4 mL/(kg · min) until delivery . The dilatation stopped immediately after delivery , and puerperal received routine infusion according to haemodynamics .Before anesthesia ,5 min after anesthesia ,the systolic/diastolic ratios (S/D) ,pulsatility index (PI)and resistance index (RI)were detected by using color Doppler ultrasound .After delivery ,the umbilical artery blood and umbilical veins blood were analyzed ,and the Apgar scores were compared .Phenylephrine 0 .1 mg was applied for hypotension during surgery .Results:After spinal‐epidural anesthesia ,the umbilical artery PI and S/D in two groups were reduced .There was no statistical significance of RI between before anesthesia and after anesthesia or between two groups . The incidence of hypotension during surgery in H group was lower than that in R group (P=0 .03) .The phenylephrine requirements in R group was higher than that in H group (P=0 .001) .There was no statistical significance of blood gas analysis and Apgar score in two groups .Conclusions :The spinal‐epidural anesthesia can lower the resistance of umbilical artery blood .Comparing to Lactated Ringer′s solution ,colloid coload significantly increased placental perfusion ,and decrease the incidence rate of hypotension during surgery .
6.Effects of N-Arachidonoylethanolamine on the quality of platelets stored in M-sol platelet preservative solution in vitro.
Yun-Long ZHUANG ; Yi ZHANG ; Wen-Ben QIAO ; Yuan YU ; Ming LIN ; Qing ZHU ; Juan ZHOU ; Gui-Zhi SUN ; Cui-Yun ZHAO ; Xiang-Min NIE ; Hong LIU ; Yuan-Feng CHEN ; Chuan-Fu ZHU
Journal of Experimental Hematology 2013;21(5):1285-1290
This study was purposed to investigate the effects of N-Arachidonoylethanolamine (ANA) on the quality of platelets (Plt) stored in Plt M-sol preservative solution at 22 ± 2°C. Samples taken from collecting apheresis Plt by the Amicus instrument and splited into two equal parts were stored in Plt M-sol preservative solution on a shaker at 22 ± 2°C. Different working concentrations of ANA (from 0.1 to 50 µmol/L) were then added into one part of stored Plt as the experimental group, the other without ANA was used as the control group. The viability of Plts stored at 22 ± 2°C for 7 days was evaluated by MTT colorimetric assay. The most effective concentration of ANA was selected and added to the subsequent experimental group. Plt count (BPC), mean Plt volume (MPV), Plt distribution width (PDW), phosphatidyl serine (PS) and soluble P-selectin were detected on the 1(st), 5(th), 7(th), 9(th) and 11(th) day of storage. The results showed that the most effective working concentration of ANA was 0.5 µmol/L, which showed significant increasing Plt viability (91.23 ± 5.44%) compared to the control group (62.54 ± 4.79%). Thus, ANA concentration at 0.5 µmol/L was choose to perform subsequent experiments. During 11 days of storage, the BPC, MPV and PDW were not changed significantly between the experimental group and control group, although there was decreasing trend in the BPC and increasing trends in MPV and PDW in the two groups. The rate of Plt PS positive was enhanced during the storage period: the rate of PS positive in experimental group increased from 7.69 ± 1.82% to 10.74 ± 1.78% while it in control group increased from 11.21 ± 2.03% to 15.37 ± 1.95%, with significant differences between the two groups (P < 0.05) on the 9(th) and 11(th) day of storage, respectively. Soluble P-selectin contents in experimental group on the 9(th) and 11(th) day of storage were 30.19 ± 2.03 ng/ml and 34.52 ± 2.64 ng/mL, respectively, while those in control group were 39.18 ± 2.66 ng/ml and 43.23 ± 2.58 ng/ml, respectively, with significant differences between the two groups (P < 0.05). It is concluded that the extended storage of Plt in M-sol treated with low concentration ANA can potentially alleviate Plt storage lesions.
Adult
;
Blood Platelets
;
drug effects
;
Blood Preservation
;
Endocannabinoids
;
pharmacology
;
Female
;
Humans
;
Male
7.A field trial for evaluating the safety of recombinant human interferon alpha-2b for nasal spray.
Qing CHEN ; Li-lan ZHANG ; De-xian YU ; Zhi-ai YU ; Yi LIU ; Li-ping ZHANG ; Zhi-feng LI ; Zhao-jun DUAN ; Bin-hui WANG ; Xue-jun WEI ; Gui-fang HU ; Yu-qing LIU ; Xin-wei CHU ; Yan-hong HAN ; Min WU ; Xiao-ling JIANG ; Jian-dong LI ; Ying-chun DAI ; Jun NIE ; Jun LONG ; Li ZHU ; Su-xia SUN ; Yong-yu RUI ; Ding-kang ZHANG ; Shou-yi YU ; Yun-de HOU
Chinese Journal of Experimental and Clinical Virology 2005;19(3):211-215
OBJECTIVETo evaluate the safety of recombinant human interferon alpha-2b for nasal spray for the prevention of SARS and other upper respiratory viral infections.
METHODSField epidemiologic evaluation was conducted, the design was randomized and had a synchronously parallel control group. In the study, the drugs were given for five days and all subjects were followed up for ten days.
RESULTSDuring the period of using interferon, body temperature of the experimental group was normal compared to the control group. Experimental group had more influenza-like symptoms than the control group (P < 0.05), such as headache (4.83%-7.09%), dizziness (7.17%-11.63%), lassitude (8.55%-15.06%), muscular soreness (4.43%-7.09%), pharynx dryness (12.10%-17.85%), angina (6.25%-8.72%), abdominal pain (2.30%-5.50%) and diarrhea (2.45%-5.66%). Most of side effects reached their peak with in the first 3 days. Except for pharynx dryness, the incidences of all other side effects declined after completion of the use of the trial drug, and incidences of some symptoms in experimental group were lower than those of the control group. There were no significant differences in the symptoms of cough and expectoration between the experimental group and the control group. The incidence of exanthem in the control group was significantly higher than that in the experimental group. The side effect of bloody nasal mucus was not observed in experimental group, which had been reported by other authors in several volunteer studies.
CONCLUSIONUsing recombinant human interferon alpha-2b for nasal spray could lead to some influenza-like symptoms, however, all those symptoms were mild , reversible, and relieved after completion of the use of the trial drug. No serious side effects were found during the period of following up. The authors conclude that the drug is safe.
Abdominal Pain ; chemically induced ; Adolescent ; Adult ; Antiviral Agents ; administration & dosage ; adverse effects ; therapeutic use ; Dizziness ; chemically induced ; Female ; Follow-Up Studies ; Headache ; chemically induced ; Humans ; Interferon-alpha ; administration & dosage ; adverse effects ; therapeutic use ; Male ; Recombinant Proteins ; SARS Virus ; drug effects ; Severe Acute Respiratory Syndrome ; prevention & control ; virology ; Treatment Outcome ; Young Adult
8.Comprehensive identification of metabolites and metabolic characteristics of luteolin and kaempferol in Simiao Yong'an Decoction in rats by UHPLC-LTQ-Orbitrap MS/MS.
Man-Fang YANG ; Hui LI ; Xin-Rui XU ; Qing-Yue ZHANG ; Tian-Yu WANG ; Lu FENG ; Gui-Yang XIA ; Zhan QIN ; Bo NIE
China Journal of Chinese Materia Medica 2023;48(22):6191-6199
Simiao Yong'an Decoction is a classic prescription for treating gangrene. Modern medical evidence has proven that Si-miao Yong'an Decoction has therapeutic effects on atherosclerosis(AS), vascular occlusion angeitides, and hypertension, while its pharmacodynamic mechanism remains unclear. The evidence of network pharmacology, molecular docking, literature review, and our previous study suggests that luteolin and kaempferol are two major flavonoids in Simiao Yong'an Decoction and can inhibit macrophage inflammation and exert anti-AS effects. However, due to lack of the metabolism studies in vivo, little is known about the metabolic characteristics of luteolin and kaempferol. This study employed ultra-performance liquid chromatography coupled with linear ion trap-Orbitrap mass spectrometry(UHPLC-LTQ-Orbitrap MS/MS) and relevant software to identify the metabolites and metabolic pathways of luteolin and kaempferol in rat plasma, urine, and feces, after oral administration of luteolin and kaempferol, respectively. After the administration of luteolin, 10, 11, and 3 metabolites of luteolin were detected in the plasma, urine, and feces, respectively. After the administration of kaempferol, 9, 3, and 1 metabolites of kaempferol were detected in the plasma, urine, and feces, respectively. The metabolic pathways mainly involved methylation, glucuronidation, and sulfation. This study enriches the knowledge about the pharmacological mechanism of luteolin and kaempferol and supplies a reference for revealing the metabolic process of other flavonoids in Simiao Yong'an Decoction, which is of great significance for elucidating the pharmacological effects and effective substances of this decoction in vivo.
Rats
;
Animals
;
Tandem Mass Spectrometry/methods*
;
Luteolin/analysis*
;
Drugs, Chinese Herbal/chemistry*
;
Kaempferols/analysis*
;
Chromatography, High Pressure Liquid/methods*
;
Molecular Docking Simulation
9.Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing.
Rui JIN ; Kui-Jun ZHAO ; Gui-Ming GUO ; Bing ZHANG ; Yu-Guang WANG ; Chun-Miao XUE ; Yi-Heng YANG ; Li-Xia WANG ; Guo-Hui LI ; Jin-Fa TANG ; Li-Xing NIE ; Xiang-Lin ZHANG ; Ting-Ting ZHAO ; Yi ZHANG ; Can YAN ; Suo-Zhong YUAN ; Lu-Lu SUN ; Xing-Zhong FENG ; Dan YAN ; Null
China Journal of Chinese Materia Medica 2018;43(5):1049-1053
With the growth of number of Chinese patent medicines and clinical use, the rational use of Chinese medicine is becoming more and more serious. Due to the complexity of Chinese medicine theory and the uncertainty of clinical application, the prescription review of Chinese patent medicine always relied on experience in their respective, leading to the uncontrolled of clinical rational use. According to the traditional Chinese medicine (TCM) theory and characteristics of the unique clinical therapeutics, based on the practice experience and expertise comments, our paper formed the expert consensus on the prescription review of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing. The objective, methods and key points of prescription review of Chinese patent medicine, were included in this expert consensus, in order to regulate the behavior of prescription and promote rational drug use.
10.Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients (version 2024)
Yao LU ; Yang LI ; Leiying ZHANG ; Hao TANG ; Huidan JING ; Yaoli WANG ; Xiangzhi JIA ; Li BA ; Maohong BIAN ; Dan CAI ; Hui CAI ; Xiaohong CAI ; Zhanshan ZHA ; Bingyu CHEN ; Daqing CHEN ; Feng CHEN ; Guoan CHEN ; Haiming CHEN ; Jing CHEN ; Min CHEN ; Qing CHEN ; Shu CHEN ; Xi CHEN ; Jinfeng CHENG ; Xiaoling CHU ; Hongwang CUI ; Xin CUI ; Zhen DA ; Ying DAI ; Surong DENG ; Weiqun DONG ; Weimin FAN ; Ke FENG ; Danhui FU ; Yongshui FU ; Qi FU ; Xuemei FU ; Jia GAN ; Xinyu GAN ; Wei GAO ; Huaizheng GONG ; Rong GUI ; Geng GUO ; Ning HAN ; Yiwen HAO ; Wubing HE ; Qiang HONG ; Ruiqin HOU ; Wei HOU ; Jie HU ; Peiyang HU ; Xi HU ; Xiaoyu HU ; Guangbin HUANG ; Jie HUANG ; Xiangyan HUANG ; Yuanshuai HUANG ; Shouyong HUN ; Xuebing JIANG ; Ping JIN ; Dong LAI ; Aiping LE ; Hongmei LI ; Bijuan LI ; Cuiying LI ; Daihong LI ; Haihong LI ; He LI ; Hui LI ; Jianping LI ; Ning LI ; Xiying LI ; Xiangmin LI ; Xiaofei LI ; Xiaojuan LI ; Zhiqiang LI ; Zhongjun LI ; Zunyan LI ; Huaqin LIANG ; Xiaohua LIANG ; Dongfa LIAO ; Qun LIAO ; Yan LIAO ; Jiajin LIN ; Chunxia LIU ; Fenghua LIU ; Peixian LIU ; Tiemei LIU ; Xiaoxin LIU ; Zhiwei LIU ; Zhongdi LIU ; Hua LU ; Jianfeng LUAN ; Jianjun LUO ; Qun LUO ; Dingfeng LYU ; Qi LYU ; Xianping LYU ; Aijun MA ; Liqiang MA ; Shuxuan MA ; Xainjun MA ; Xiaogang MA ; Xiaoli MA ; Guoqing MAO ; Shijie MU ; Shaolin NIE ; Shujuan OUYANG ; Xilin OUYANG ; Chunqiu PAN ; Jian PAN ; Xiaohua PAN ; Lei PENG ; Tao PENG ; Baohua QIAN ; Shu QIAO ; Li QIN ; Ying REN ; Zhaoqi REN ; Ruiming RONG ; Changshan SU ; Mingwei SUN ; Wenwu SUN ; Zhenwei SUN ; Haiping TANG ; Xiaofeng TANG ; Changjiu TANG ; Cuihua TAO ; Zhibin TIAN ; Juan WANG ; Baoyan WANG ; Chunyan WANG ; Gefei WANG ; Haiyan WANG ; Hongjie WANG ; Peng WANG ; Pengli WANG ; Qiushi WANG ; Xiaoning WANG ; Xinhua WANG ; Xuefeng WANG ; Yong WANG ; Yongjun WANG ; Yuanjie WANG ; Zhihua WANG ; Shaojun WEI ; Yaming WEI ; Jianbo WEN ; Jun WEN ; Jiang WU ; Jufeng WU ; Aijun XIA ; Fei XIA ; Rong XIA ; Jue XIE ; Yanchao XING ; Yan XIONG ; Feng XU ; Yongzhu XU ; Yongan XU ; Yonghe YAN ; Beizhan YAN ; Jiang YANG ; Jiangcun YANG ; Jun YANG ; Xinwen YANG ; Yongyi YANG ; Chunyan YAO ; Mingliang YE ; Changlin YIN ; Ming YIN ; Wen YIN ; Lianling YU ; Shuhong YU ; Zebo YU ; Yigang YU ; Anyong YU ; Hong YUAN ; Yi YUAN ; Chan ZHANG ; Jinjun ZHANG ; Jun ZHANG ; Kai ZHANG ; Leibing ZHANG ; Quan ZHANG ; Rongjiang ZHANG ; Sanming ZHANG ; Shengji ZHANG ; Shuo ZHANG ; Wei ZHANG ; Weidong ZHANG ; Xi ZHANG ; Xingwen ZHANG ; Guixi ZHANG ; Xiaojun ZHANG ; Guoqing ZHAO ; Jianpeng ZHAO ; Shuming ZHAO ; Beibei ZHENG ; Shangen ZHENG ; Huayou ZHOU ; Jicheng ZHOU ; Lihong ZHOU ; Mou ZHOU ; Xiaoyu ZHOU ; Xuelian ZHOU ; Yuan ZHOU ; Zheng ZHOU ; Zuhuang ZHOU ; Haiyan ZHU ; Peiyuan ZHU ; Changju ZHU ; Lili ZHU ; Zhengguo WANG ; Jianxin JIANG ; Deqing WANG ; Jiongcai LAN ; Quanli WANG ; Yang YU ; Lianyang ZHANG ; Aiqing WEN
Chinese Journal of Trauma 2024;40(10):865-881
Patients with severe trauma require an extremely timely treatment and transfusion plays an irreplaceable role in the emergency treatment of such patients. An increasing number of evidence-based medicinal evidences and clinical practices suggest that patients with severe traumatic bleeding benefit from early transfusion of low-titer group O whole blood or hemostatic resuscitation with red blood cells, plasma and platelet of a balanced ratio. However, the current domestic mode of blood supply cannot fully meet the requirements of timely and effective blood transfusion for emergency treatment of patients with severe trauma in clinical practice. In order to solve the key problems in blood supply and blood transfusion strategies for emergency treatment of severe trauma, Branch of Clinical Transfusion Medicine of Chinese Medical Association, Group for Trauma Emergency Care and Multiple Injuries of Trauma Branch of Chinese Medical Association, Young Scholar Group of Disaster Medicine Branch of Chinese Medical Association organized domestic experts of blood transfusion medicine and trauma treatment to jointly formulate Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients ( version 2024). Based on the evidence-based medical evidence and Delphi method of expert consultation and voting, 10 recommendations were put forward from two aspects of blood support mode and transfusion strategies, aiming to provide a reference for transfusion resuscitation in the emergency treatment of severe trauma and further improve the success rate of treatment of patients with severe trauma.